Brad N. Taylor,Rajeshwari Mehta,Tohru Yamada,Craig Beattie,Tapas Das Gupta
申请号：
US12338480
公开号：
US09968685B2
申请日:
2008.12.18
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention discloses methods and materials for killing and/or inhibiting the growth of a cancer cell via preferential entry of a cytotoxic compound. Preferential entry of the cytotoxic compound is accomplished by the use of protein transduction domains derived from cupredoxins, including the p18 and p28 truncations of azurin.
